Cora Sternberg presented an analysis of the nature and manageability of adverse events (AEs) of ipatasertib and abiraterone within the context of the IPATential150 trial (NCT03072238) which compared this combination therapy to abiraterone along as a first-line treatment approach in metastatic castration resistant prostate cancer (mCRPC)
As one of the leading Weight Loss Centers in Charlotte NC, we are dedicated to supporting your overall wellness journey, ensuring you have the tools you need to thrive
Hormone therapy, particularly when used for anti-aging purposes, can carry risks such as increased incidence of certain cancers, cardiovascular disease, and other health issues
As the curtains closed on Ozempic's unexpected weight loss plot twist, the stage was set for a new star to rise: Wegovy (also semaglutide)
Frohman LA et al
Hepatoprotective effect of combination of L-carnitine and magnesium-hydroxide in nonalcoholic fatty liver disease patients: a double-blinded randomized controlled pilot study